{"id":"https://openalex.org/W1490716924","doi":"https://doi.org/10.1002/j.1875-9114.1982.tb03191.x","title":"Alprazolam: Pharmacokinetics, Clinical Efficacy, and Mechanism of Action","display_name":"Alprazolam: Pharmacokinetics, Clinical Efficacy, and Mechanism of Action","publication_year":1982,"publication_date":"1982-09-10","ids":{"openalex":"https://openalex.org/W1490716924","doi":"https://doi.org/10.1002/j.1875-9114.1982.tb03191.x","mag":"1490716924","pmid":"https://pubmed.ncbi.nlm.nih.gov/6133268"},"language":"en","primary_location":{"id":"doi:10.1002/j.1875-9114.1982.tb03191.x","doi":"https://doi.org/10.1002/j.1875-9114.1982.tb03191.x","is_oa":false,"landing_page_url":"https://doi.org/10.1002/j.1875-9114.1982.tb03191.x","pdf_url":null,"source":{"id":"https://openalex.org/S122731057","display_name":"Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy","issn_l":"0277-0008","issn":["0277-0008","1875-9114"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5111659801","display_name":"JAN A. FAWCETT","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1285301757","display_name":"Rush University Medical Center","ror":"https://ror.org/01j7c0b24","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1285301757"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Jan A. Fawcett","raw_affiliation_strings":["Departments of Psychiatry and Psychology and Social Sciences, Rush-Presbyterian-St. Luke's Medical Center, Chicago"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Departments of Psychiatry and Psychology and Social Sciences, Rush-Presbyterian-St. Luke's Medical Center, Chicago","institution_ids":["https://openalex.org/I1285301757"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5043976413","display_name":"Howard M. Kravitz","orcid":"https://orcid.org/0000-0001-8013-783X","observed_orcids":["https://orcid.org/0000-0001-8013-783X"]},"institutions":[{"id":"https://openalex.org/I1285301757","display_name":"Rush University Medical Center","ror":"https://ror.org/01j7c0b24","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1285301757"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Howard M. Kravitz","raw_affiliation_strings":["Departments of Psychiatry and Psychology and Social Sciences, Rush-Presbyterian-St. Luke's Medical Center, Chicago"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Departments of Psychiatry and Psychology and Social Sciences, Rush-Presbyterian-St. Luke's Medical Center, Chicago","institution_ids":["https://openalex.org/I1285301757"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5111659801"],"corresponding_institution_ids":["https://openalex.org/I1285301757"],"apc_list":{"value":4030,"currency":"USD","value_usd":4030},"apc_paid":null,"fwci":5.8247,"has_fulltext":false,"cited_by_count":88,"citation_normalized_percentile":{"value":0.95904173,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":88,"max":98},"biblio":{"volume":"2","issue":"5","first_page":"243","last_page":"253"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10853","display_name":"Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes","score":0.7139000296592712,"subfield":{"id":"https://openalex.org/subfields/3205","display_name":"Experimental and Cognitive Psychology"},"field":{"id":"https://openalex.org/fields/32","display_name":"Psychology"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},"topics":[{"id":"https://openalex.org/T10853","display_name":"Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes","score":0.7139000296592712,"subfield":{"id":"https://openalex.org/subfields/3205","display_name":"Experimental and Cognitive Psychology"},"field":{"id":"https://openalex.org/fields/32","display_name":"Psychology"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},{"id":"https://openalex.org/T13105","display_name":"Synthesis and pharmacology of benzodiazepine derivatives","score":0.13779999315738678,"subfield":{"id":"https://openalex.org/subfields/1605","display_name":"Organic Chemistry"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},{"id":"https://openalex.org/T11071","display_name":"Treatment of Major Depression","score":0.07209999859333038,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/alprazolam","display_name":"alprazolam","score":1.0},{"id":"https://openalex.org/keywords/triazolobenzodiazepines","display_name":"triazolobenzodiazepines","score":0.9240000247955322},{"id":"https://openalex.org/keywords/benzodiazepines","display_name":"benzodiazepines","score":0.9350000023841858},{"id":"https://openalex.org/keywords/pharmacokinetics","display_name":"pharmacokinetics","score":0.9950000047683716},{"id":"https://openalex.org/keywords/anxiolytic-efficacy","display_name":"anxiolytic efficacy","score":0.8059999942779541},{"id":"https://openalex.org/keywords/anxiety-disorders","display_name":"anxiety disorders","score":0.9660000205039978},{"id":"https://openalex.org/keywords/panic-disorder","display_name":"panic disorder","score":0.7639999985694885},{"id":"https://openalex.org/keywords/elderly-patients","display_name":"elderly patients","score":0.8790000081062317},{"id":"https://openalex.org/keywords/sleepiness","display_name":"sleepiness","score":0.8679999709129333},{"id":"https://openalex.org/keywords/drug-interactions","display_name":"drug interactions","score":0.7350000143051147},{"id":"https://openalex.org/keywords/antidepressant-efficacy","display_name":"antidepressant efficacy","score":0.5239999890327454},{"id":"https://openalex.org/keywords/diazepam-comparison","display_name":"diazepam comparison","score":0.6840000152587891}],"concepts":[{"id":"https://openalex.org/C2777196872","wikidata":"https://www.wikidata.org/wiki/Q319877","display_name":"Alprazolam","level":3,"score":0.9940297603607178},{"id":"https://openalex.org/C2777765862","wikidata":"https://www.wikidata.org/wiki/Q62903","display_name":"Anxiolytic","level":3,"score":0.674888014793396},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.6364918947219849},{"id":"https://openalex.org/C2778325228","wikidata":"https://www.wikidata.org/wiki/Q178566","display_name":"Chlordiazepoxide","level":3,"score":0.6256860494613647},{"id":"https://openalex.org/C558461103","wikidata":"https://www.wikidata.org/wiki/Q154430","display_name":"Anxiety","level":2,"score":0.6148250102996826},{"id":"https://openalex.org/C2776175493","wikidata":"https://www.wikidata.org/wiki/Q210402","display_name":"Diazepam","level":2,"score":0.61152583360672},{"id":"https://openalex.org/C2778173252","wikidata":"https://www.wikidata.org/wiki/Q83871","display_name":"Benzodiazepine","level":3,"score":0.5937468409538269},{"id":"https://openalex.org/C2779911313","wikidata":"https://www.wikidata.org/wiki/Q845224","display_name":"Generalized anxiety disorder","level":3,"score":0.528410792350769},{"id":"https://openalex.org/C2780712732","wikidata":"https://www.wikidata.org/wiki/Q208450","display_name":"Panic","level":3,"score":0.5054628849029541},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.5054268836975098},{"id":"https://openalex.org/C2781081902","wikidata":"https://www.wikidata.org/wiki/Q3539074","display_name":"Tricyclic","level":2,"score":0.4980638027191162},{"id":"https://openalex.org/C112705442","wikidata":"https://www.wikidata.org/wiki/Q323936","display_name":"Pharmacokinetics","level":2,"score":0.45462799072265625},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.4375845491886139},{"id":"https://openalex.org/C2776867660","wikidata":"https://www.wikidata.org/wiki/Q1814941","display_name":"Depression (economics)","level":2,"score":0.4339959919452667},{"id":"https://openalex.org/C2777529043","wikidata":"https://www.wikidata.org/wiki/Q741713","display_name":"Panic disorder","level":3,"score":0.42480435967445374},{"id":"https://openalex.org/C118552586","wikidata":"https://www.wikidata.org/wiki/Q7867","display_name":"Psychiatry","level":1,"score":0.25577259063720703},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.24831590056419373},{"id":"https://openalex.org/C139719470","wikidata":"https://www.wikidata.org/wiki/Q39680","display_name":"Macroeconomics","level":1,"score":0.0},{"id":"https://openalex.org/C162324750","wikidata":"https://www.wikidata.org/wiki/Q8134","display_name":"Economics","level":0,"score":0.0},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.0}],"mesh":[{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000525","descriptor_name":"Alprazolam","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D001008","descriptor_name":"Anxiety Disorders","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D001569","descriptor_name":"Benzodiazepines","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D001569","descriptor_name":"Benzodiazepines","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D001569","descriptor_name":"Benzodiazepines","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D002621","descriptor_name":"Chemistry","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D002986","descriptor_name":"Clinical Trials as Topic","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D003863","descriptor_name":"Depression","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D004341","descriptor_name":"Drug Evaluation","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004361","descriptor_name":"Drug Tolerance","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007700","descriptor_name":"Kinetics","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D014151","descriptor_name":"Anti-Anxiety Agents","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D014151","descriptor_name":"Anti-Anxiety Agents","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D014151","descriptor_name":"Anti-Anxiety Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D055598","descriptor_name":"Chemical Phenomena","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1002/j.1875-9114.1982.tb03191.x","doi":"https://doi.org/10.1002/j.1875-9114.1982.tb03191.x","is_oa":false,"landing_page_url":"https://doi.org/10.1002/j.1875-9114.1982.tb03191.x","pdf_url":null,"source":{"id":"https://openalex.org/S122731057","display_name":"Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy","issn_l":"0277-0008","issn":["0277-0008","1875-9114"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy","raw_type":"journal-article"},{"id":"pmid:6133268","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/6133268","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Pharmacotherapy","raw_type":"Clinical Trial"}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.9763000011444092,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":67,"referenced_works":["https://openalex.org/W54501116","https://openalex.org/W102272118","https://openalex.org/W155179578","https://openalex.org/W635543726","https://openalex.org/W1507444347","https://openalex.org/W1509963353","https://openalex.org/W1515603362","https://openalex.org/W1729771355","https://openalex.org/W1966466951","https://openalex.org/W1967795096","https://openalex.org/W1968016568","https://openalex.org/W1977616150","https://openalex.org/W1979769975","https://openalex.org/W1982904143","https://openalex.org/W1985036614","https://openalex.org/W1987336827","https://openalex.org/W1992456051","https://openalex.org/W1993090539","https://openalex.org/W1994306318","https://openalex.org/W1995003813","https://openalex.org/W2003629454","https://openalex.org/W2007570230","https://openalex.org/W2007911341","https://openalex.org/W2017331493","https://openalex.org/W2018609775","https://openalex.org/W2027628754","https://openalex.org/W2029928771","https://openalex.org/W2029930431","https://openalex.org/W2033969410","https://openalex.org/W2039079946","https://openalex.org/W2042232934","https://openalex.org/W2046785640","https://openalex.org/W2049746713","https://openalex.org/W2050057350","https://openalex.org/W2052499021","https://openalex.org/W2056872485","https://openalex.org/W2062110904","https://openalex.org/W2062316523","https://openalex.org/W2065047452","https://openalex.org/W2066944493","https://openalex.org/W2067495470","https://openalex.org/W2067911360","https://openalex.org/W2083651915","https://openalex.org/W2086204218","https://openalex.org/W2095133554","https://openalex.org/W2103259855","https://openalex.org/W2114613490","https://openalex.org/W2127950250","https://openalex.org/W2135133199","https://openalex.org/W2150287316","https://openalex.org/W2315364274","https://openalex.org/W2315672138","https://openalex.org/W2335918034","https://openalex.org/W2396907711","https://openalex.org/W2397351380","https://openalex.org/W2407879384","https://openalex.org/W2413380625","https://openalex.org/W2413530658","https://openalex.org/W2416393206","https://openalex.org/W2418179442","https://openalex.org/W2433994651","https://openalex.org/W2462958848","https://openalex.org/W2465164904","https://openalex.org/W2914090811","https://openalex.org/W2917896665","https://openalex.org/W3157784817","https://openalex.org/W4249506570"],"related_works":["https://openalex.org/W153563570","https://openalex.org/W2103259855","https://openalex.org/W2085958346","https://openalex.org/W2016942629","https://openalex.org/W2031244179","https://openalex.org/W1247911372","https://openalex.org/W2118160252","https://openalex.org/W47806681","https://openalex.org/W36420567","https://openalex.org/W2433994651"],"abstract_inverted_index":{"Alprazolam,":[0],"a":[1,34,136],"triazolobenzodiazepine,":[2],"is":[3,55,70,113,147],"the":[4,17,45,72,91,114,120],"first":[5],"of":[6,10,37,49,74,79,93,117,122,139,198],"this":[7],"new":[8],"class":[9],"benzodiazepine":[11],"drugs":[12,196],"to":[13,29,39,51,98,169,174],"be":[14,170,186],"marketed":[15],"in":[16,27,44,119,129],"United":[18],"States":[19],"and":[20,32,60,77,135,161,183],"Canada.":[21],"It":[22],"achieves":[23],"peak":[24],"serum":[25,35],"levels":[26],"0.7":[28],"2.1":[30],"hours":[31],"has":[33,126],"half-life":[36],"12":[38],"15":[40],"hours.":[41],"When":[42],"given":[43],"recommended":[46],"daily":[47],"dosage":[48],"0.5":[50],"4.0":[52],"mg,":[53],"it":[54],"as":[56,58,62],"effective":[57],"diazepam":[59,153],"chlordiazepoxide":[61],"an":[63],"anxiolytic":[64],"agent.":[65],"Its":[66,142],"currently":[67,87],"approved":[68,89],"indication":[69],"for":[71,90,191],"treatment":[73,92,121],"anxiety":[75,82],"disorders":[76],"symptoms":[78],"anxiety,":[80],"including":[81],"associated":[83],"with":[84,106,132],"depression.":[85],"Although":[86],"not":[88],"depressive":[94],"disorders,":[95],"studies":[96],"published":[97],"date":[99],"have":[100],"demonstrated":[101],"that":[102,150],"alprazolam":[103,118,167,190],"compares":[104],"favorably":[105],"standard":[107],"tricyclic":[108],"antidepressants.":[109],"Also":[110],"undergoing":[111],"investigation":[112],"potential":[115,199],"role":[116],"panic":[123],"disorders.":[124],"Alprazolam":[125],"been":[127],"used":[128],"elderly":[130],"patients":[131,192],"beneficial":[133],"results":[134],"low":[137],"frequency":[138],"adverse":[140],"reactions.":[141],"primary":[143],"side":[144],"effect,":[145],"drowsiness,":[146],"less":[148],"than":[149],"produced":[151],"by":[152],"at":[154,171],"comparable":[155,173],"doses.":[156],"Data":[157],"on":[158],"toxicity,":[159],"tolerance,":[160],"withdrawal":[162],"profile":[163],"are":[164,180],"limited,":[165,182],"but":[166],"seems":[168],"least":[172],"other":[175,194],"benzodiazepines.":[176],"Drug":[177],"interaction":[178],"data":[179],"also":[181],"care":[184],"should":[185],"exercised":[187],"when":[188],"prescribing":[189],"taking":[193],"psychotropic":[195],"because":[197],"additive":[200],"depressant":[201],"effects.":[202]},"counts_by_year":[{"year":2025,"cited_by_count":1},{"year":2024,"cited_by_count":5},{"year":2023,"cited_by_count":2},{"year":2022,"cited_by_count":2},{"year":2021,"cited_by_count":1},{"year":2020,"cited_by_count":1},{"year":2015,"cited_by_count":1},{"year":2013,"cited_by_count":1}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2016-06-24T00:00:00"}